Interview

Cancer survival rates in the UK have doubled over the past 50 years due to advancements in early diagnosis and treatment, with Cancer Research UK (CRUK) playing a key role by funding nearly £400 million in research annually. In an interview with Katie Sloan, an investment manager at Cancer Research Horizons, we highlight CRH's efforts in accelerating oncology innovation, including supporting early-stage ventures like Trogenix, which is developing a novel gene therapy platform targeting aggressive cancers such as glioblastoma, with promising preclinical results and planned clinical trials in 2025.

Lucy Ahern

April 3, 2025

Genetic engineering is a fast-paced field and biotech Forge Genetics, offers a unique technology called Forge Editing, to catapult the industry further. We have covered Forge Genetics in a previous Start-up Spotlight, where you can read a more in-depth summary of their background. But here we will discuss Forge Genetics' vision for the future and how they look to tackle their upcoming challenges.

Ariyana Rayatt

December 13, 2024